Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Merkel Cell Carcinoma of Skin: early-phase trial registry
2 of 3 indexed Merkel Cell Carcinoma of Skin trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #5,209 of 28,707 conditions by registered trial count.
3 US clinical trials · 2 currently recruiting · #5,209 of 28,707 conditions by registered trial count
Merkel Cell Carcinoma of Skin: 3 US clinical trials tracked, 2 recruiting.
Merkel Cell Carcinoma of Skin is the subject of 3 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Phio Pharmaceuticals, running 1 of these trials.
Enrollment posture brief
Registry condition merkel-cell-carcinoma-of-skin
OPEN 2 | RECR 67% | LATE 0 | EARLY 2 | RANK #5209 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acute Hypoxemic Respiratory Failure (67% recruiting · 6 trials)
Merkel Cell Carcinoma of Skin lists 2 open slots (67% of 3 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Merkel Cell Carcinoma of Skin on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Merkel Cell Carcinoma of Skin is recruiting above its size-band peers.
2 of 3 indexed trials (66.7%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
Open and recent trials
3 total, page 1 of 1
A Study of VET3-TGI in Patients With Solid Tumors
KaliVir Immunotherapeutics
NCT06444815
Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers
University of Wisconsin, Madison
NCT06608511
Intratumoral PH-762 for Cutaneous Carcinoma
Phio Pharmaceuticals
NCT06014086
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Merkel Cell Carcinoma of Skin records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Merkel Cell Carcinoma of Skin trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Merkel Cell Carcinoma of Skin page
3 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Merkel Cell Carcinoma of Skin trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Phio Pharmaceuticals sponsors the most Merkel Cell Carcinoma of Skin trials on record, review their full trial history before evaluating a specific study. See Phio Pharmaceuticals's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Merkel Cell Carcinoma of Skin condition card totals 3 registered trials; most-linked intervention PH-762; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.